Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005288475 | SCV005956305 | uncertain significance | Inborn genetic diseases | 2025-03-14 | criteria provided, single submitter | clinical testing | The p.I134V variant (also known as c.400A>G), located in coding exon 3 of the USB1 gene, results from an A to G substitution at nucleotide position 400. The isoleucine at codon 134 is replaced by valine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |